On October 5, 2026 Aprea Therapeutics, Inc. (Nasdaq: APRE) ("Aprea", or the "Company"), a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers, reported that Oren Gilad PhD, President and CEO, will participate in the 2026 Maxim Growth Summit, to take place October 12-14 in New York City and the Regional Biotechnology Conference, to take place October 15 in Doylestown, PA.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Maxim Growth Summit

Date and Time: Wednesday, October 14, 9am ET
Format: Fireside Chat
Location: Hard Rock Hotel, New York City

A webcast of the fireside chat will be available on demand to registered conference attendees. For more information and a complete agenda, please refer to View Source

If you would like to arrange a 1on1 meeting with Aprea management during the conference, please contact your Maxim representative.

Regional Biotechnology Conference 2026

Date and Time: Thursday, October 15, 9am – 12noon ET
Format: Panel Discussions
Location: Pennsylvania Biotechnology Center
3805 Old Easton Road, Doylestown, PA 18902

For more information and a complete agenda, please refer to View Source

(Press release, Aprea, OCT 5, 2026, View Source [SID1234673188])